Skip to main content
Pandemics, Patents, and Price Controls
Researchers at the UW Medicine Retrovirology Research Lab at Harborview Medical Center work on samples from the Novavax phase 3 Covid-19 clinical vaccine trial on February 12, 2021 in Seattle, Washington
(Photo by Karen Ducey/Getty Images)

Pandemics, Patents, and Price Controls

Adam Mossoff


The COVID-19 pandemic has shown the world what decades of patent protection has made possible in the biopharmaceutical sector of the U.S. innovation economy. Nonetheless, price controls now threaten to stifle this innovation. If the government twists its own laws and arbitrarily imposes price controls on patented vaccines and drugs created by pharmaceutical innovators, innovation will not occur. Statist price controls kill innovation, destroy markets, and stymie or degrade economic development. We should prevent politicians and activists from exploiting the COVID-19 crisis to undermine both patents and biopharmaceutical advancement—harming people today and preventing an effective response to the next pandemic.

Read the full report in Heritage Foundation

Related Articles

Republicans Can Embrace Much of Biden’s Anticorruption Plan

Nate Sibley

Kleptocracy deprives the developing world of trillions of dollars each year, fueling poverty and conflict while entrenching powerful regimes in China,...

Continue Reading

Hudson Institute Celebrates 60th Anniversary

Hudson Institute

Hudson Institute celebrates its 60th anniversary this year, marking more than half a century of policy research dedicated to keeping America and its a...

Continue Reading

Comment on National Institute of Standards and Technology Study on China's Involvement in Standard Development Organizations

Adam Mossoff et al.

Response to the FR Doc. 2021-24090 (Docket Number 211026-0219), Request for Information on the Study on People’s Republic of China (PRC) Policies and...

Continue Reading